Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Press releaseGlobeNewswire· March 26, 2026

DBV Technologies publie ses résultats financiers annuels 2025 et fait le point sur ses activités

“Trésorerie et équivalents de trésorerie de 194 millions de dollars au 31 décembre 2025”

Verbatim excerpt from the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

DBV is pleased with the progress made in strengthening capabilities and building a company ready for the launch of Viaskin Peanut
60% confidence
These estimates are based on the Company's current forecasts and exclude any additional expenses related to programs other than Viaskin Peanut, or resulting from potential licensing or acquisition operations of additional product candidates or technologies
60% confidence
The Company may have based these estimates on assumptions that could prove to be inaccurate, and could consequently use its resources more quickly than anticipated
60% confidence
Management estimates that the Company has sufficient resources to fund operations through the second quarter of 2027
60% confidence
DBV remains firmly committed to making Viaskin Peanut available to children aged 1 to 7 years allergic to peanuts
60% confidence
We approached 2025 focused on strengthening the company's financial position, completing the VITESSE study, launching the COMFORT Toddlers study, and preparing for the BLA submission and potential commercial launch in the United States
60% confidence